Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial

Table 2

Posttrabeculectomy cataract surgery patients: descriptive statistics.

Group I	Group II	value	Number of patients	Group I	Group II
63.21 ± 9.24 years	65.42 ± 11.1 years	0.59	N = patients	21	27
Parameter	Preoperative value		value	Postoperative value		value
Groups	Group I	Group II		Group I	Group II
IOP	28.42 ± 4.20	27.6 ± 5.00	0.62	14.34 ± 2.34	15.10 ± 3.30	0.83
CDVA	0.54 ± 0.36	0.46 ± 0.14	0.24	0.30 ± 0.25	0.24 ± 0.20	0.28
Diurnal IOP	3.87 ± 3.31	3.77 ± 1.42	0.80	2.77 ± 0.69	2.82 ± 1.0	0.82
Number of medications	2.96 ± 1.21	2.82 ± 1.6	0.78	0.09 ± 0.04	0.13 ± 0.09	0.72
Duration of medicine use	4.14 ± 4.0 years	4.14 ± 4.0 years	0.46

Group I: 11 males and 10 females; Group II: 11 males and 16 females.